Abstract
Introduction: The rate of nodal positivity (ypN+) after neoadjuvant chemotherapy in patients diagnosed with node-negative (cN0) breast cancer is low. Sentinel lymph node biopsy (SNLB) may be of limited value in select patients. The aim of this study was to determine the rate of axillary ypN0 in patients with cN0 disease treated with neoadjuvant chemotherapy (NACT) and to identify clinicopathological features associated with ypN0.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical oncology (Royal College of Radiologists (Great Britain))
Paper Title
Journal
Date
